MiRNA marker for Kawasaki disease coronary artery injury and application thereof
A technique for coronary artery disease and Kawasaki disease, applied in the field of gene markers, can solve the problems of lack of MiR-26a and restriction of early diagnosis and treatment of KD
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0026] Twenty children diagnosed with KD in the Department of Cardiology, Hebei Children's Hospital from June 2020 to September 2021 were selected and included in the KD group. Scientific Statements for Health Professionals" [1]. Another 20 healthy children from the Health Department of Hebei Children's Hospital were selected as the control group. In the KD group, there were 11 males and 9 females with an average age of 2.4±1.1 years; in the control group, there were 10 males and 10 females with an average age of 3.1±1.4 years; there was no significant difference in gender and age between the two groups ( P>0.05). The blood collection time of the KD children was before the administration of gamma globulin after the diagnosis of KD; the blood collection time of the children in the control group was during the physical examination in the Children's Health Department of our hospital. 3 ml of peripheral blood samples were collected from two groups of children, centrifuged at 200...
PUM

Abstract
Description
Claims
Application Information

- R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com